Lisata Therapeutics, Inc. (LSTA)
1.21
-0.07
(-5.47%)
USD |
NASDAQ |
Nov 13, 16:00
1.23
+0.02
(+1.65%)
After-Hours: 19:59
Lisata Therapeutics Shareholders Equity (Quarterly) : 7.643M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 7.643M |
| June 30, 2026 | 8.244M |
| March 31, 2026 | 10.93M |
| December 31, 2025 | 14.86M |
| September 30, 2025 | 17.37M |
| June 30, 2025 | 21.03M |
| March 31, 2025 | 25.36M |
| December 31, 2024 | 29.57M |
| September 30, 2024 | 33.69M |
| June 30, 2024 | 38.25M |
| March 31, 2024 | 43.00M |
| December 31, 2023 | 48.15M |
| September 30, 2023 | 52.96M |
| June 30, 2023 | 57.97M |
| March 31, 2023 | 60.96M |
| December 31, 2022 | 66.58M |
| September 30, 2022 | 72.02M |
| June 30, 2022 | 82.39M |
| March 31, 2022 | 88.50M |
| December 31, 2021 | 92.25M |
| September 30, 2021 | 98.67M |
| June 30, 2021 | 104.93M |
| March 31, 2021 | 110.27M |
| December 31, 2020 | 32.50M |
| September 30, 2020 | 37.74M |
| Date | Value |
|---|---|
| June 30, 2020 | 33.81M |
| March 31, 2020 | 17.24M |
| December 31, 2019 | 20.82M |
| September 30, 2019 | 25.25M |
| June 30, 2019 | 29.89M |
| March 31, 2019 | 34.73M |
| December 31, 2018 | 37.73M |
| September 30, 2018 | 41.08M |
| June 30, 2018 | 43.74M |
| March 31, 2018 | 45.59M |
| December 31, 2017 | 50.51M |
| September 30, 2017 | 53.33M |
| June 30, 2017 | 54.42M |
| March 31, 2017 | -0.791M |
| December 31, 2016 | 24.28M |
| September 30, 2016 | 10.75M |
| June 30, 2016 | 6.050M |
| March 31, 2016 | 33.06M |
| December 31, 2015 | 23.71M |
| September 30, 2015 | 55.43M |
| June 30, 2015 | 66.38M |
| March 31, 2015 | 50.40M |
| December 31, 2014 | 58.51M |
| September 30, 2014 | 63.00M |
| June 30, 2014 | 78.04M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
| Arrowhead Pharmaceuticals, Inc. | 50.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 648.41M |
| Total Liabilities (Quarterly) | 630.10M |
| Debt to Equity Ratio | 75.29 |
| Current Ratio | 14.09 |
| Net Debt Paydown Yield | -739.7% |